We are live on ! Find out more
RVLP

RVL Pharmaceuticals plc Ordinary Shares
RVLP

Delisted

RVLP was delisted on the 20th of October, 2023.

Back to rankings

60 hedge funds and large institutions have $31M invested in RVL Pharmaceuticals plc Ordinary Shares in 2020 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 22 increasing their positions, 22 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 22

3% less funds holding

Funds holding: 62 → 60 (-2)

22% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 9

31% less capital invested

Capital invested by funds: $45.1M → $31M (-$14.1M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
60
Holders Change
-2
Holders Change %
-3.23%
% of All Funds
1.06%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
7
Increased
22
Reduced
22
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$5.63M
2
WCM
Wedge Capital Management
North Carolina
+$1.28M
3
MF
Magnetar Financial
Illinois
+$782K
4
BFM
Boothbay Fund Management
New York
+$193K
5
Renaissance Technologies
Renaissance Technologies
New York
+$167K

Top Sellers

Rank Fund Capital Flow
1
DCM
DG Capital Management
New York
-$5.74M
2
CCM
CAAS Capital Management
New York
-$2.62M
3
Marshall Wace
Marshall Wace
United Kingdom
-$1.1M
4
SSA
Schonfeld Strategic Advisors
New York
-$819K
5
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$668K
Name Holding Trade Value Shares
Change 		Change in
Stake
MAM
26
Martingale Asset Management
Massachusetts
$103K -$228K -39,547 -61%
California State Teachers Retirement System (CalSTRS)
27
California State Teachers Retirement System (CalSTRS)
California
$86K +$14.1K +2,439 +13%
Deutsche Bank
28
Deutsche Bank
Germany
$80K +$77.2K +13,394 +221%
HW
29
Hancock Whitney
Mississippi
$76K – – –
FA
30
Forefront Analytics
Pennsylvania
$72K -$14.8K -2,564 -12%
TI
31
Trexquant Investment
Connecticut
$72K +$101K +17,467 New
Wells Fargo
32
Wells Fargo
California
$71K -$59.8K -10,372 -37%
AQR Capital Management
33
AQR Capital Management
Connecticut
$66K -$312K -54,175 -77%
RhumbLine Advisers
34
RhumbLine Advisers
Massachusetts
$64K +$8.27K +1,435 +10%
IA
35
Insight Advisors
Pennsylvania
$61K +$85.3K +14,800 New
ProShare Advisors
36
ProShare Advisors
Maryland
$51K +$3.5K +608 +5%
CCM
37
CAAS Capital Management
New York
$45K -$2.62M -455,338 -98%
RJA
38
Raymond James & Associates
Florida
$44K +$61.8K +10,725 New
Jane Street
39
Jane Street
New York
$42K +$58.5K +10,144 New
Invesco
40
Invesco
Georgia
$42K +$58.5K +10,152 New
Bank of America
41
Bank of America
North Carolina
$24K -$305K -52,885 -90%
JP Morgan Chase
42
JP Morgan Chase
New York
$23K +$4.44K +770 +16%
Citigroup
43
Citigroup
New York
$19K +$1.54K +267 +6%
Barclays
44
Barclays
United Kingdom
$17K -$9.2K -1,596 -27%
TRCT
45
Tower Research Capital (TRC)
New York
$16K -$15.7K -2,718 -41%
Lazard Asset Management
46
Lazard Asset Management
New York
$16K +$23.1K +4,011 New
BNP Paribas Financial Markets
47
BNP Paribas Financial Markets
France
$15.4K +$7.73K +1,341 +56%
Federated Hermes
48
Federated Hermes
Pennsylvania
$14K +$542 +94 +3%
Bank of Montreal
49
Bank of Montreal
Ontario, Canada
$9K +$7.95K +1,379 +229%
Legal & General Group
50
Legal & General Group
United Kingdom
$7K – – –
1
2
3

RVLP Hedge Fund Activity: Q4 2020 in Review

60 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in RVL Pharmaceuticals plc Ordinary Shares (RVLP) for Q4 2020, worth a combined $31M — down 31% from $45.1M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of RVLP and 7 opened new positions — a net loss of 2 holders — while 22 trimmed existing stakes and 22 added.

The largest buyer was Morgan Stanley, adding an estimated $5.63M. The largest seller was DG Capital Management, cutting an estimated $5.74M.

  • 60 institutional investors held RVL Pharmaceuticals plc Ordinary Shares (RVLP) as of Q4 2020, down from 62 in Q3 2020.
  • Funds reported $31M of RVL Pharmaceuticals plc Ordinary Shares stock for Q4 2020, down 31% quarter-over-quarter.
  • 7 funds opened new RVL Pharmaceuticals plc Ordinary Shares positions in Q4 2020 and 9 closed out, a net change of -2 holders.
  • The largest RVL Pharmaceuticals plc Ordinary Shares buyer in Q4 2020 was Morgan Stanley, an estimated $5.63M added.
  • The largest RVL Pharmaceuticals plc Ordinary Shares seller in Q4 2020 was DG Capital Management, an estimated $5.74M sold.

Based on aggregated 13F filings for Q4 2020.